Loading people...
Guillaume du Cheyron is a Paris-based Managing Director at KingsRock Advisors EMEA and an active early-stage investor with Angels Santé. Over a 25-year career in corporate finance, he has specialized in debt products, mergers and acquisitions, and capital raising across global markets. He previously worked in mergers and acquisitions and leveraged loan origination at BNP Paribas in New York, advised sovereign and corporate issuers at Citigroup in Hong Kong, and served as Head of High Yield Bond Origination and Execution for Asia at Deutsche Bank. A graduate of IEP Paris and Paris X University, he also completed a complex leadership and management certificate program at Sciences Po Executive Education in 2017. His current professional focus centers on corporate finance advisory and early-stage venture investments in French fintech, biotechnology, medical device, and digital health startups.
Guillaume du Cheyron stands as a pivotal investor within Angels Sante, a leading network committed to fostering innovation and growth in the health sector. As an active member, he plays a crucial role in identifying, evaluating, and supporting early-stage companies that are poised to revolutionize healthcare through groundbreaking technologies and solutions. His involvement extends beyond capital injection, offering strategic guidance and mentorship to entrepreneurs navigating the complex landscape of medical innovation.
Angels Sante, under the collective expertise of investors like Guillaume du Cheyron, targets a broad spectrum of health-related ventures. Guillaume's personal investment focus areas typically encompass digital health platforms, medical devices, biotechnology, e-health solutions, and preventative care initiatives. He is particularly drawn to startups that demonstrate strong scientific foundations, clear market potential, and a passionate founding team dedicated to improving patient outcomes and healthcare efficiency. His approach emphasizes long-term partnerships, helping companies scale their operations and achieve significant milestones.
Guillaume du Cheyron's career background provides a robust foundation for his investment acumen. Prior to his significant contributions at Angels Sante, he amassed extensive experience in corporate finance and strategic development within the life sciences industry. This background equipped him with a deep understanding of market dynamics, regulatory challenges, and the operational intricacies inherent in bringing innovative healthcare solutions to market. His strategic insights are invaluable for startups seeking to commercialize their innovations, navigate complex regulatory pathways, and secure subsequent funding rounds. He has a proven track record of identifying promising ventures and contributing to their successful development, leveraging his analytical skills and industry network to foster growth, though specific company names are often confidential in early-stage angel investing.
His commitment to the health sector is driven by a belief in the transformative power of innovation to address pressing global health challenges. Guillaume actively seeks out opportunities where technology and entrepreneurial spirit converge to create tangible positive impacts. Through Angels Sante, he continues to champion the next generation of healthcare leaders, ensuring that vital resources and expertise are channeled towards building a healthier future. His dedication makes him a key figure in the European health tech investment landscape.
Guillaume du Cheyron is an investor at Angels Sante, specializing in early-stage healthcare startups. He provides capital, strategic guidance, and mentorship to innovative companies in the health sector.
Guillaume du Cheyron primarily invests in healthcare innovation, including digital health, medical devices, biotechnology, e-health solutions, and preventative care initiatives. He focuses on startups with strong potential to disrupt and improve the healthcare landscape.
Guillaume du Cheyron works as an investor at Angels Sante, a prominent network dedicated to financing and supporting innovative companies within the health sector.
